Renee Jo James
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
POR Featured in Dividend Champion List. Portland General Electric was highlighted in a recent Seeking Alpha article focusing on dividend champions, contenders, and challengers. This recognition underscores the stock's appeal to income-focused investors, given its 4.58% dividend yield. The news provides context for the stock's current trading levels, which are near its 52-week low and showing signs of support rejection.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Oracle: No Recent Company News. Oracle has not had any new company‑specific announcements in the past week. The recent news items listed relate to other technology firms and do not directly affect Oracle’s operations or outlook. Investors can continue to rely on existing fundamentals and market data for guidance.
Transaction History
| C | ▲ Buy | Grant | 6 | $854 | 10/1/2026 | View on chart |
| C | ▲ Buy | Grant | 160 | $21K | 10/1/2026 | View on chart |
| POR | ▲ Buy | Grant | 3,073 | $160K | 7/24/2026 | View on chart |
| C | ▲ Buy | Grant | 5 | $762 | 7/1/2026 | View on chart |
| C | ▲ Buy | Grant | 132 | $19K | 7/1/2026 | View on chart |
| C | ▲ Buy | Grant | 7 | $758 | 4/1/2026 | View on chart |
| C | ▲ Buy | Grant | 168 | $19K | 4/1/2026 | View on chart |
| C | ▲ Buy | Grant | 145 | $17K | 1/2/2026 | View on chart |
| C | ▲ Buy | Grant | 11 | $1K | 1/2/2026 | View on chart |
| C | ▲ Buy | Grant | 1,263 | $0 | 1/2/2026 | View on chart |
| C | ▲ Buy | Grant | 168 | $17K | 10/1/2025 | View on chart |
| C | ▲ Buy | Grant | 13 | $1K | 10/1/2025 | View on chart |
| POR | ▲ Buy | Grant | 3,873 | $155K | 7/18/2025 | View on chart |
| C | ▲ Buy | Grant | 190 | $16K | 7/1/2025 | View on chart |
| C | ▲ Buy | Grant | 14 | $1K | 7/1/2025 | View on chart |
| POR | ▲ Buy | Grant | 294 | $12K | 6/11/2025 | View on chart |
| C | ▲ Buy | Grant | 16 | $1K | 4/1/2025 | View on chart |
| C | ▲ Buy | Grant | 219 | $16K | 4/1/2025 | View on chart |
| C | ▲ Buy | Grant | 2,118 | $0 | 1/2/2025 | View on chart |
| C | ▲ Buy | Grant | 24 | $2K | 1/2/2025 | View on chart |
| C | ▲ Buy | Grant | 197 | $14K | 1/2/2025 | View on chart |
| C | ▲ Buy | Grant | 225 | $14K | 10/1/2024 | View on chart |
| C | ▲ Buy | Grant | 27 | $2K | 10/1/2024 | View on chart |
| C | ▲ Buy | Grant | 210 | $13K | 7/1/2024 | View on chart |
| C | ▲ Buy | Grant | 25 | $2K | 7/1/2024 | View on chart |
| ORCL | ▲ Buy | Option Exercise | 3,303 | — | 5/31/2024 | View on chart |
| C | ▲ Buy | Grant | 208 | $13K | 4/1/2024 | View on chart |
| C | ▲ Buy | Grant | 25 | $2K | 4/1/2024 | View on chart |
| C | ▲ Buy | Grant | 188 | $10K | 1/2/2024 | View on chart |
| C | ▲ Buy | Grant | 61 | $3K | 1/2/2024 | View on chart |
| C | ▲ Buy | Grant | 2,923 | $0 | 1/2/2024 | View on chart |
| C | ▲ Buy | Grant | 233 | $10K | 10/1/2023 | View on chart |
| C | ▲ Buy | Grant | 75 | $3K | 10/1/2023 | View on chart |
| C | ▲ Buy | Grant | 196 | $9K | 7/1/2023 | View on chart |
| C | ▲ Buy | Grant | 63 | $3K | 7/1/2023 | View on chart |
| ORCL | ▲ Buy | Option Exercise | 4,866 | — | 5/31/2023 | View on chart |
| C | ▲ Buy | Grant | 196 | $9K | 4/1/2023 | View on chart |
| C | ▲ Buy | Grant | 63 | $3K | 4/1/2023 | View on chart |
| C | ▲ Buy | Grant | 3,353 | $0 | 1/3/2023 | View on chart |
| C | ▲ Buy | Grant | 166 | $8K | 1/1/2023 | View on chart |
| C | ▲ Buy | Grant | 54 | $2K | 1/1/2023 | View on chart |
| C | ▲ Buy | Grant | 153 | $8K | 10/1/2022 | View on chart |
| C | ▲ Buy | Grant | 49 | $2K | 10/1/2022 | View on chart |
| C | ▲ Buy | Grant | 149 | $7K | 7/1/2022 | View on chart |
| C | ▲ Buy | Grant | 48 | $2K | 7/1/2022 | View on chart |
| ORCL | ▲ Buy | Option Exercise | 4,445 | — | 5/31/2022 | View on chart |
| ORCL | ▼ Sell | Open Market | 6,000 | $505K | 4/4/2022 | View on chart |
| C | ▲ Buy | Grant | 131 | $7K | 4/1/2022 | View on chart |
| C | ▲ Buy | Grant | 22 | $1K | 4/1/2022 | View on chart |
| C | ▲ Buy | Grant | 2,255 | $0 | 2/10/2022 | View on chart |
| C | ▲ Buy | Grant | 36 | $2K | 1/1/2022 | View on chart |
| C | ▲ Buy | Grant | 101 | $6K | 1/1/2022 | View on chart |
| C | ▲ Buy | Grant | 89 | $6K | 10/1/2021 | View on chart |
| C | ▲ Buy | Grant | 32 | $2K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
US presses China on Citigroup market access in Bangkok talks
The U.S. government has raised concerns about Citigroup's market access in China during bilateral talks in Bangkok. This diplomatic development highlights the ongoing regulatory and geopolitical risks associated with the bank's international operations. While Citi also initiated coverage on other companies like Mobileye, the trade discussions are the primary factor affecting the stock's broader outlook.
US presses China on Citigroup market access in Bangkok talks. The U.S. government has raised concerns about Citigroup's market access in China during bilateral talks in Bangkok. This diplomatic development highlights the ongoing regulatory and geopolitical risks associated with the bank's international operations. While Citi also initiated coverage on other companies like Mobileye, the trade discussions are the primary factor affecting the stock's broader outlook.